CANTEX PHARMACEUTICALS INC. 13D and 13G filings for Chimerix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-03 4:16 pm Sale |
2021-12-31 | 13G | Chimerix, Inc. CMRX |
CANTEX PHARMACEUTICALS INC. | 3,500,000 4.000% |
-6,500,000![]() (-65.00%) |
Filing |